Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Date
Availability
1-50 of 71
Keywords: Alzheimer's disease
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Articles
Journal:
Biochemical Journal
Biochem J (2025) 482 (12): 877–899.
Published: 17 June 2025
.... The most studied PTMs of tau are phosphorylation and acetylation; however, the salience of other PTMs is not fully explored. Tissue transglutaminase (TG) is an enzyme whose activity is elevated in Alzheimer’s disease (AD). TG action on tau may lead to intramolecular and intermolecular cross-linking along...
Includes: Supplementary data
Articles
Piyali Majumder, Kaushik Chanda, Debajyoti Das, Brijesh Kumar Singh, Partha Chakrabarti, Nihar Ranjan Jana, Debashis Mukhopadhyay
Journal:
Biochemical Journal
Biochem J (2021) 478 (17): 3297–3317.
Published: 14 September 2021
...Piyali Majumder; Kaushik Chanda; Debajyoti Das; Brijesh Kumar Singh; Partha Chakrabarti; Nihar Ranjan Jana; Debashis Mukhopadhyay Alzheimer's Disease (AD) and Type 2 Diabetes (T2D) share a common hallmark of insulin resistance. Reportedly, two non-canonical Receptor Tyrosine Kinases (RTKs), ALK...
Includes: Supplementary data
Articles
Spontaneous protein–protein crosslinking at glutamine and glutamic acid residues in long-lived proteins
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2021) 478 (2): 327–339.
Published: 22 January 2021
... were enabled. Correspondence: Michael G. Friedrich ([email protected]) 18 10 2020 15 12 2020 18 12 2020 21 12 2020 © 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2021 age Alzheimer's disease human lens...
Includes: Supplementary data
Articles
Amyloid-beta oligomers induce Parkin-mediated mitophagy by reducing Miro1
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2020) 477 (23): 4581–4597.
Published: 08 December 2020
...Min Kyoung Kam; Dong Gil Lee; Bokyung Kim; Jae-Won Huh; Hong Jun Lee; Young-Ho Park; Dong-Seok Lee Alzheimer's disease (AD) is a neurodegenerative disease associated with the accumulation of amyloid-beta oligomers (AβO). Recent studies have demonstrated that mitochondria-specific autophagy...
Includes: Supplementary data
Articles
Journal:
Biochemical Journal
Biochem J (2020) 477 (11): 2039–2054.
Published: 10 June 2020
...John R. Horsley; Blagojce Jovcevski; Kate L. Wegener; Jingxian Yu; Tara L. Pukala; Andrew D. Abell Amyloid beta peptide (Aβ 42 ) aggregation in the brain is thought to be responsible for the onset of Alzheimer's disease, an insidious condition without an effective treatment or cure. Hence...
Articles
Molecular dynamics of C99-bound γ-secretase reveal two binding modes with distinct compactness, stability, and active-site retention: implications for Aβ production
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2019) 476 (7): 1173–1189.
Published: 15 April 2019
...Budheswar Dehury; Ning Tang; Kasper P. Kepp The membrane protease γ-secretase cleaves the C99 fragment of the amyloid precursor protein, thus producing the Aβ peptides central to Alzheimer's disease. Cryo-electron microscopy has provided the topology but misses the membrane and loop parts...
Includes: Supplementary data
Articles
Cysteine-rich granulin-3 rapidly promotes amyloid-β fibrils in both redox states
Available to PurchaseAnukool A. Bhopatkar, Gaurav Ghag, Lauren M. Wolf, Dexter N. Dean, Melissa A. Moss, Vijayaraghavan Rangachari
Journal:
Biochemical Journal
Biochem J (2019) 476 (5): 859–873.
Published: 12 March 2019
...) and Alzheimer's disease (AD). Their precise mechanism in these pathologies remains uncertain, but both inflammatory and lysosomal roles have been observed for GRNs. Among the seven GRNs, GRN-3 is well characterized and is implicated within the context of FTD. However, the relationship between GRN-3 and amyloid-β...
Includes: Supplementary data
Articles
An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viability
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2018) 475 (19): 3087–3103.
Published: 10 October 2018
...Ofek Oren; Victor Banerjee; Ran Taube; Niv Papo Aggregation and accumulation of the 42-residue amyloid β peptide (Aβ42) in the extracellular matrix and within neuronal cells is considered a major cause of neuronal cell cytotoxicity and death in Alzheimer's disease (AD) patients. Therefore...
Includes: Supplementary data
Articles
ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity
Available to PurchaseIoannis Dafnis, Christina Raftopoulou, Christina Mountaki, Evgenia Megalou, Vassilis I. Zannis, Angeliki Chroni
Journal:
Biochemical Journal
Biochem J (2018) 475 (10): 1839–1859.
Published: 31 May 2018
...Ioannis Dafnis; Christina Raftopoulou; Christina Mountaki; Evgenia Megalou; Vassilis I. Zannis; Angeliki Chroni The β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) initiates the production of amyloid-β peptide (Aβ), which is central to the pathogenesis of Alzheimer's disease (AD...
Includes: Supplementary data
Articles
Molecular basis for the interaction between stress-inducible phosphoprotein 1 (STIP1) and S100A1
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2017) 474 (11): 1853–1866.
Published: 16 May 2017
... ) 1 12 2016 11 4 2017 13 4 2017 13 4 2017 © 2017 The Author(s); published by Portland Press Limited on behalf of the Biochemical Society 2017 Alzheimer's disease calcium signaling co-chaperone NMR spectroscopy tetratricopeptide repeat The S100 family...
Includes: Supplementary data
Articles
Astrocytic transporters in Alzheimer's disease
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2017) 474 (3): 333–355.
Published: 20 January 2017
... in neurological diseases, including Alzheimer's disease (AD). These changes may reflect a change from a neuroprotective to a neurotoxic phenotype. Given the lack of current disease-modifying therapies for AD, astrocytes have become an interesting and viable target for therapeutic intervention. The astrocyte...
Articles
Dementia-related Bri2 BRICHOS is a versatile molecular chaperone that efficiently inhibits Aβ42 toxicity in Drosophila
Available to PurchaseHelen Poska, Martin Haslbeck, Firoz Roshan Kurudenkandy, Erik Hermansson, Gefei Chen, George Kostallas, Axel Abelein, Henrik Biverstål, Sophie Crux, André Fisahn, Jenny Presto, Jan Johansson
Journal:
Biochemical Journal
Biochem J (2016) 473 (20): 3683–3704.
Published: 11 October 2016
... in Alzheimer's disease (AD), for which no effective treatment exists. The BRICHOS domain is a part of several disease-related proproteins, the most studied ones being Bri2 associated with familial dementia and prosurfactant protein C (proSP-C) associated with lung amyloid. BRICHOS from proSP-C has been found...
Includes: Supplementary data
Articles
Physiological and pathophysiological functions of Swiprosin-1/EFhd2 in the nervous system
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2016) 473 (16): 2429–2437.
Published: 11 August 2016
...Dirk Mielenz; Frank Gunn-Moore Synaptic dysfunction and dysregulation of Ca 2+ are linked to neurodegenerative processes and behavioural disorders. Our understanding of the causes and factors involved in behavioural disorders and neurodegeneration, especially Alzheimer's disease (AD), a tau-related...
Articles
Domains of STIP1 responsible for regulating PrP C -dependent amyloid-β oligomer toxicity
Available to PurchaseAndrzej Maciejewski, Valeriy G. Ostapchenko, Flavio H. Beraldo, Vania F. Prado, Marco A.M. Prado, Wing-Yiu Choy
Journal:
Biochemical Journal
Biochem J (2016) 473 (14): 2119–2130.
Published: 12 July 2016
...Andrzej Maciejewski; Valeriy G. Ostapchenko; Flavio H. Beraldo; Vania F. Prado; Marco A.M. Prado; Wing-Yiu Choy Soluble oligomers of amyloid-beta peptide (AβO) transmit neurotoxic signals through the cellular prion protein (PrP C ) in Alzheimer's disease (AD). Secreted stress-inducible...
Articles
BRICHOS binds to a designed amyloid-forming β-protein and reduces proteasomal inhibition and aggresome formation
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2016) 473 (2): 167–178.
Published: 05 January 2016
...Lisa Dolfe; Bengt Winblad; Jan Johansson; Jenny Presto The BRICHOS domain is associated with proliferative, degenerative and amyloid diseases, and it has been shown to inhibit fibril formation and toxicity of the Alzheimer's disease-associated amyloid β-peptide. ProSP-C (prosurfactant protein C...
Includes: Supplementary data
Articles
Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions
Available to PurchaseYasuhiko Kizuka, Miyako Nakano, Shinobu Kitazume, Takashi Saito, Takaomi C. Saido, Naoyuki Taniguchi
Journal:
Biochemical Journal
Biochem J (2016) 473 (1): 21–30.
Published: 09 December 2015
...Yasuhiko Kizuka; Miyako Nakano; Shinobu Kitazume; Takashi Saito; Takaomi C. Saido; Naoyuki Taniguchi β-Site amyloid precursor protein-cleaving enzyme-1 (BACE1) is a protease essential for amyloid-β (Aβ) production in Alzheimer's disease (AD). BACE1 protein is known to be up-regulated by oxidative...
Includes: Supplementary data
Articles
Phosphorylation of FE65 Ser 610 by serum- and glucocorticoid-induced kinase 1 modulates Alzheimer's disease amyloid precursor protein processing
Available to PurchaseWan Ning Vanessa Chow, Jacky Chi Ki Ngo, Wen Li, Yu Wai Chen, Ka Ming Vincent Tam, Ho Yin Edwin Chan, Christopher C.J. Miller, Kwok-Fai Lau
Journal:
Biochemical Journal
Biochem J (2015) 470 (3): 303–317.
Published: 04 September 2015
...Wan Ning Vanessa Chow; Jacky Chi Ki Ngo; Wen Li; Yu Wai Chen; Ka Ming Vincent Tam; Ho Yin Edwin Chan; Christopher C.J. Miller; Kwok-Fai Lau Alzheimer's disease (AD) is a fatal neurodegenerative disease affecting 36 million people worldwide. Genetic and biochemical research indicate...
Includes: Supplementary data
Articles
Cu 2+ accentuates distinct misfolding of Aβ (1–40) and Aβ (1–42) peptides, and potentiates membrane disruption
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2015) 466 (2): 233–242.
Published: 20 February 2015
...Christian J. Matheou; Nadine D. Younan; John H. Viles Central to Alzheimer's disease is the misfolding of amyloid-beta (Aβ) peptide, which generates an assorted population of amorphous aggregates, oligomers and fibres. Metal ion homoeostasis is disrupted in the brains of sufferers of Alzheimer's...
Articles
Fe65 Ser 228 is phosphorylated by ATM/ATR and inhibits Fe65–APP-mediated gene transcription
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2015) 465 (3): 413–421.
Published: 22 January 2015
... of Alzheimer's disease (AD) and AICD has important roles in the regulation of gene transcription (in complex with Fe65). It is therefore important to understand how Fe65 is regulated and how this contributes to the function and/or processing of APP. Studies have also implicated Fe65 in the cellular DNA damage...
Articles
Specific aromatic foldamers potently inhibit spontaneous and seeded Aβ42 and Aβ43 fibril assembly
Open AccessKatelyn M. Seither, Heather A. McMahon, Nikita Singh, Hejia Wang, Mimi Cushman-Nick, Geronda L. Montalvo, William F. DeGrado, James Shorter
Journal:
Biochemical Journal
Biochem J (2014) 464 (1): 85–98.
Published: 23 October 2014
...Katelyn M. Seither; Heather A. McMahon; Nikita Singh; Hejia Wang; Mimi Cushman-Nick; Geronda L. Montalvo; William F. DeGrado; James Shorter Amyloid fibrils are self-propagating entities that spread pathology in several devastating disorders including Alzheimer's disease (AD). In AD, amyloid-β (Aβ...
Articles
Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2014) 463 (2): 177–189.
Published: 22 September 2014
... adults with DS (Down's syndrome) and AD (Alzheimer's disease). Since AD pathology is age-dependent in DS and shows similarities with AD, identification of common oxidized proteins by redox proteomics in both DS and AD can improve our understanding of the overlapping mechanisms that lead from normal aging...
Articles
Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity
Available to PurchaseKristen E. Funk, Stefani N. Thomas, Kelsey N. Schafer, Grace L. Cooper, Zhongping Liao, David J. Clark, Austin J. Yang, Jeff Kuret
Journal:
Biochemical Journal
Biochem J (2014) 462 (1): 77–88.
Published: 24 July 2014
...Kristen E. Funk; Stefani N. Thomas; Kelsey N. Schafer; Grace L. Cooper; Zhongping Liao; David J. Clark; Austin J. Yang; Jeff Kuret In Alzheimer's disease, the microtubule-associated protein tau dissociates from the neuronal cytoskeleton and aggregates to form cytoplasmic inclusions. Although...
Articles
Aβ dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies
Available to PurchaseTiernan T. O’Malley, Nur Alia Oktaviani, Dainan Zhang, Aleksey Lomakin, Brian O’Nuallain, Sara Linse, George B. Benedek, Michael J. Rowan, Frans A. A. Mulder, Dominic M. Walsh
Journal:
Biochemical Journal
Biochem J (2014) 461 (3): 413–426.
Published: 10 July 2014
...Tiernan T. O’Malley; Nur Alia Oktaviani; Dainan Zhang; Aleksey Lomakin; Brian O’Nuallain; Sara Linse; George B. Benedek; Michael J. Rowan; Frans A. A. Mulder; Dominic M. Walsh Dimers of Aβ (amyloid β-protein) are believed to play an important role in Alzheimer's disease. In the absence...
Includes: Supplementary data
Articles
Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase
Available to PurchaseFlorian Nachon, Eugénie Carletti, Cyril Ronco, Marie Trovaslet, Yvain Nicolet, Ludovic Jean, Pierre-Yves Renard
Journal:
Biochemical Journal
Biochem J (2013) 453 (3): 393–399.
Published: 12 July 2013
...Florian Nachon; Eugénie Carletti; Cyril Ronco; Marie Trovaslet; Yvain Nicolet; Ludovic Jean; Pierre-Yves Renard The multifunctional nature of Alzheimer's disease calls for MTDLs (multitarget-directed ligands) to act on different components of the pathology, like the cholinergic dysfunction...
Articles
Regulation of cholinergic activity by the vesicular acetylcholine transporter
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2013) 450 (2): 265–274.
Published: 15 February 2013
... The Authors Journal compilation © 2013 Biochemical Society 2013 Alzheimer’s disease heart failure Parkinson’s disease sepsis synaptic vesicle vascular dementia Cholinergic neurons in the CNS (central nervous system) and in the periphery secrete the neurotransmitter ACh (acetylcholine...
Includes: Multimedia, Supplementary data
Articles
Anke Wahler, Anja-Silke Beyer, Ilona E. Keller, Cathrin Schnack, Björn von Einem, Christian Pröpper, Tobias M. Boeckers, Ithan D. Peltan, Dudley K. Strickland, Bradley T. Hyman, Christine A. F. von Arnim
Journal:
Biochemical Journal
Biochem J (2013) 450 (2): 333–343.
Published: 15 February 2013
...) have been implicated in the pathogenesis of AD (Alzheimer's disease). They are functionally linked by Fe65, a PTB (phosphotyrosine-binding)-domain-containing adaptor protein that binds to intracellular NPxY-motifs of APP and LRP1, thereby influencing expression levels, cellular trafficking...
Articles
Is the Amyloid Hypothesis of Alzheimer's disease therapeutically relevant?
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2012) 446 (2): 165–177.
Published: 14 August 2012
...Andrew F. Teich; Ottavio Arancio The conventional view of AD (Alzheimer's disease) is that much of the pathology is driven by an increased load of β-amyloid in the brain of AD patients (the ‘Amyloid Hypothesis’). Yet, many therapeutic strategies based on lowering β-amyloid have so far failed...
Articles
The anti-neurodegenerative agent clioquinol regulates the transcription factor FOXO1a
Available to PurchaseAmy R. Cameron, Katherine Wallace, Lisa Logie, Alan R. Prescott, Terry G. Unterman, Jean Harthill, Graham Rena
Journal:
Biochemical Journal
Biochem J (2012) 443 (1): 57–64.
Published: 14 March 2012
...Amy R. Cameron; Katherine Wallace; Lisa Logie; Alan R. Prescott; Terry G. Unterman; Jean Harthill; Graham Rena Many diseases of aging including AD (Alzheimer's disease) and T2D (Type 2 diabetes) are strongly associated with common risk factors, suggesting that there may be shared aging mechanisms...
Articles
Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease
Available to PurchaseSurabhi Bhatia, Bianca Knoch, Jenny Wong, Woojin S. Kim, Paul L. Else, Aaron J. Oakley, Brett Garner
Journal:
Biochemical Journal
Biochem J (2012) 442 (3): 713–721.
Published: 24 February 2012
...Surabhi Bhatia; Bianca Knoch; Jenny Wong; Woojin S. Kim; Paul L. Else; Aaron J. Oakley; Brett Garner ApoD (apolipoprotein D) is up-regulated in AD (Alzheimer's disease) and upon oxidative stress. ApoD inhibits brain lipid peroxidation in vivo , but the mechanism is unknown. Specific methionine...
Includes: Supplementary data
Articles
Visualization of co-localization in Aβ42-administered neuroblastoma cells reveals lysosome damage and autophagosome accumulation related to cell death
Available to PurchaseVioletta Soura, Maris Stewart-Parker, Thomas L. Williams, Arjuna Ratnayaka, Joe Atherton, Kirsti Gorringe, Jack Tuffin, Elisabeth Darwent, Roma Rambaran, William Klein, Pascale Lacor, Kevin Staras, Julian Thorpe, Louise C. Serpell
Journal:
Biochemical Journal
Biochem J (2012) 441 (2): 579–590.
Published: 21 December 2011
... Biochemical Society 2012 Alzheimer's disease amyloid-β peptide-(1–42) (Aβ42) autophagosome lysosome oligomer AD (Alzheimer's disease) is characterized by deposition of assembled Aβ42 [Aβ (amyloid-β peptide)-(1–42)] peptides in extracellular amyloid plaques [ 1 ]. However, accumulating...
Includes: Supplementary data
Articles
Insights into the PX (phox-homology) domain and SNX (sorting nexin) protein families: structures, functions and roles in disease
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2012) 441 (1): 39–59.
Published: 14 December 2011
... invasion and amyloid production in Alzheimer's disease. 1 To whom correspondence should be addressed (email [email protected] ). 11 7 2011 26 7 2011 27 7 2011 © The Authors Journal compilation © 2012 Biochemical Society 2012 Alzheimer's disease endosome...
Includes: Multimedia, Supplementary data
Articles
Aβ42 oligomers, but not fibrils, simultaneously bind to and cause damage to ganglioside-containing lipid membranes
Available to PurchaseThomas L. Williams, Benjamin R. G. Johnson, Brigita Urbanc, A. Toby A. Jenkins, Simon D. A. Connell, Louise C. Serpell
Journal:
Biochemical Journal
Biochem J (2011) 439 (1): 67–77.
Published: 14 September 2011
...Thomas L. Williams; Benjamin R. G. Johnson; Brigita Urbanc; A. Toby A. Jenkins; Simon D. A. Connell; Louise C. Serpell Aβ (amyloid-β peptide) assembles to form amyloid fibres that accumulate in senile plaques associated with AD (Alzheimer's disease). The major constituent, a 42-residue Aβ, has...
Includes: Supplementary data
Articles
Aggregation of amyloids in a cellular context: modelling and experiment
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2011) 438 (3): 415–426.
Published: 26 August 2011
... of fibril growth during disease progression has been revealed by AFM ( Figure 5 ). 1 email [email protected] 28 2 2011 28 4 2011 4 5 2011 26 8 2011 © The Authors Journal compilation © 2011 Biochemical Society 2011 Alzheimer's disease computer simulation...
Includes: Multimedia, Supplementary data
Articles
Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains
Available to PurchaseLeila Hejazi, Jason W.H. Wong, Danni Cheng, Nicholas Proschogo, Diako Ebrahimi, Brett Garner, Anthony S. Don
Journal:
Biochemical Journal
Biochem J (2011) 438 (1): 165–175.
Published: 27 July 2011
...) analysis of sphingolipids based on both mass and hydrophobicity, and use this method to characterize the SM (sphingomyelin), ceramide and GalCer (galactosylceramide) content of hippocampus from AD (Alzheimer's disease) and control subjects. Using a mathematical relationship we exclude the influence...
Includes: Supplementary data
Articles
Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content of the endoplasmic reticulum (ER) and triggers ER stress
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2011) 437 (3): 469–475.
Published: 13 July 2011
... to generate a plasma-membrane Ca 2+ conductance and has been proposed to influence Alzheimer's disease risk. In the present study we have investigated the effects of CALHM1 on intracellular Ca 2+ handling in HEK-293T [HEK (human embryonic kidney)-293 cells expressing the large T-antigen of SV40 (simian virus...
Includes: Supplementary data
Articles
Glycogen synthase kinase-3β regulates Tyr 307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src
Available to PurchaseXiu-Qing Yao, Xiao-Xue Zhang, Yang-Yang Yin, Bin Liu, Dan-Ju Luo, Dan Liu, Ning-Ning Chen, Zhong-Fei Ni, Xiong Wang, Qun Wang, Jian-Zhi Wang, Gong-Ping Liu
Journal:
Biochemical Journal
Biochem J (2011) 437 (2): 335–344.
Published: 28 June 2011
... that is suppressed in the brain in AD (Alzheimer's disease). However, the molecular mechanism is not understood. In the present study we found that activation of GSK-3β stimulates the inhibitory phosphorylation of PP2A at Tyr 307 (pY307-PP2A), whereas inhibition of GSK-3β decreased the level of pY307-PP2A both...
Articles
An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2011) 437 (1): 25–34.
Published: 14 June 2011
...Marta Marín-Argany; Geovanny Rivera-Hernández; Joaquim Martí; Sandra Villegas Aβ (amyloid β) immunotherapy has been revealed as a possible tool in Alzheimer's disease treatment. In contrast with complete antibodies, the administration of scFvs (single-chain variable fragments) produces neither...
Includes: Supplementary data
Articles
GULP1 is a novel APP-interacting protein that alters APP processing
Available to PurchaseCandy Yan Hao, Michael S. Perkinton, William Wai-Lun Chan, Ho Yin Edwin Chan, Christopher C. J. Miller, Kwok-Fai Lau
Journal:
Biochemical Journal
Biochem J (2011) 436 (3): 631–639.
Published: 27 May 2011
... (Alzheimer's disease). Accumulating evidence reveals that APPc (APP C-terminal domain)-interacting proteins can influence APP processing. There is also evidence to suggest that APPc-interacting proteins work co-operatively and competitively to maintain normal APP functions and processing. Hence, identification...
Includes: Supplementary data
Articles
AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2011) 434 (3): 503–512.
Published: 24 February 2011
...Claire Thornton; Nicola J. Bright; Magdalena Sastre; Phillip J. Muckett; David Carling Hyperphosphorylation of tau is a hallmark of Alzheimer's disease and other tauopathies. Although the mechanisms underlying hyperphosphorylation are not fully understood, cellular stresses such as impaired energy...
Includes: Supplementary data
Articles
Surprising toxicity and assembly behaviour of amyloid β-protein oxidized to sulfone
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2011) 433 (2): 323–332.
Published: 22 December 2010
...Panchanan Maiti; Roberto Piacentini; Cristian Ripoli; Claudio Grassi; Gal Bitan Aβ (amyloid β-peptide) is believed to cause AD (Alzheimer's disease). Aβ42 (Aβ comprising 42 amino acids) is substantially more neurotoxic than Aβ40 (Aβ comprising 40 amino acids), and this increased toxicity correlates...
Includes: Supplementary data
Articles
Specific amino acids in the BAR domain allow homodimerization and prevent heterodimerization of sorting nexin 33
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2011) 433 (1): 75–83.
Published: 15 December 2010
... interactions and suggests that SNX9 and SNX33 have distinct molecular functions. © The Authors Journal compilation © 2011 Biochemical Society 2011 Alzheimer's disease BAR domain endocytosis molecular modelling protein dimerization sorting nexin 1 To whom correspondence should...
Includes: Supplementary data
Articles
The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2010) 426 (3): 255–270.
Published: 24 February 2010
...Kirsty E. A. Muirhead; Eva Borger; Laura Aitken; Stuart J. Conway; Frank J. Gunn-Moore The Aβ (amyloid-β peptide) has long been associated with Alzheimer's disease, originally in the form of extracellular plaques. However, in the present paper we review the growing evidence for the role of soluble...
Articles
Antiparallel β-sheet: a signature structure of the oligomeric amyloid β-peptide
Available to PurchaseEmilie Cerf, Rabia Sarroukh, Shiori Tamamizu-Kato, Leonid Breydo, Sylvie Derclaye, Yves F. Dufrêne, Vasanthy Narayanaswami, Erik Goormaghtigh, Jean-Marie Ruysschaert, Vincent Raussens
Journal:
Biochemical Journal
Biochem J (2009) 421 (3): 415–423.
Published: 15 July 2009
...Emilie Cerf; Rabia Sarroukh; Shiori Tamamizu-Kato; Leonid Breydo; Sylvie Derclaye; Yves F. Dufrêne; Vasanthy Narayanaswami; Erik Goormaghtigh; Jean-Marie Ruysschaert; Vincent Raussens AD (Alzheimer's disease) is linked to Aβ (amyloid β-peptide) misfolding. Studies demonstrate that the level...
Articles
The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP)
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2009) 418 (3): 643–650.
Published: 25 February 2009
...Ascensión Cuesta; Alberto Zambrano; María Royo; Angel Pascual The expression of the APP (amyloid precursor protein), which plays a key role in the development of AD (Alzheimer's disease), is regulated by a variety of cellular mediators in a cell-dependent manner. In this study, we present evidence...
Articles
Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2009) 417 (1): 213–222.
Published: 12 December 2008
... used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre. Both steps of the HuAChE carbamylation reaction, formation of the Michaelis complex as well as the nucleophilic process...
Articles
Mechanisms of neuronal death in disease: defining the models and the players
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2008) 415 (2): 165–182.
Published: 25 September 2008
... players in the death pathways, the current tools for examining these players and the models for studying neurological disease. Alzheimer's disease, the most common neurodegenerative disorder, and cerebral ischaemia, the most common cause of neurological death, are used to illustrate our current...
Articles
A reversible form of lysine acetylation in the ER and Golgi lumen controls the molecular stabilization of BACE1
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2007) 407 (3): 383–395.
Published: 12 October 2007
...Claudio Costantini; Mi Hee Ko; Mary Cabell Jonas; Luigi Puglielli The lipid second messenger ceramide regulates the rate of β cleavage of the Alzheimer's disease APP (amyloid precursor protein) by affecting the molecular stability of the β secretase BACE1 (β-site APP cleaving enzyme 1...
Includes: Supplementary data
Articles
Differential modulation of Alzheimer's disease amyloid β-peptide accumulation by diverse classes of metal ligands
Available to PurchaseAphrodite Caragounis, Tai Du, Gulay Filiz, Katrina M. Laughton, Irene Volitakis, Robyn A. Sharples, Robert A. Cherny, Colin L. Masters, Simon C. Drew, Andrew F. Hill, Qiao-Xin Li, Peter J. Crouch, Kevin J. Barnham, Anthony R. White
Journal:
Biochemical Journal
Biochem J (2007) 407 (3): 435–450.
Published: 12 October 2007
...Aphrodite Caragounis; Tai Du; Gulay Filiz; Katrina M. Laughton; Irene Volitakis; Robyn A. Sharples; Robert A. Cherny; Colin L. Masters; Simon C. Drew; Andrew F. Hill; Qiao-Xin Li; Peter J. Crouch; Kevin J. Barnham; Anthony R. White Biometals have an important role in AD (Alzheimer's disease...
Articles
Modulation of Aβ generation by small ubiquitin-like modifiers does not require conjugation to target proteins
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2007) 404 (2): 309–316.
Published: 14 May 2007
...Véronique Dorval; Matthew J. Mazzella; Paul M. Mathews; Ronald T. Hay; Paul E. Fraser The sequential processing of the APP (amyloid precursor protein) by the β- and γ-secretase and generation of the Aβ (amyloid-β) peptide is a primary pathological factor in AD (Alzheimer's disease). Regulation...
Includes: Supplementary data
Articles
Amide solvent protection analysis demonstrates that amyloid-β(1–40) and amyloid-β(1–42) form different fibrillar structures under identical conditions
Available to Purchase
Journal:
Biochemical Journal
Biochem J (2007) 404 (1): 63–70.
Published: 26 April 2007
...Anders Olofsson; Malin Lindhagen-Persson; A. Elisabeth Sauer-Eriksson; Anders Öhman AD (Alzheimer's disease) is a neurodegenerative disorder characterized by self-assembly and amyloid formation of the 39–43 residue long Aβ (amyloid-β)-peptide. The most abundant species, Aβ(1–40) and Aβ(1–42...
1